![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 23002 |
FusionGeneSummary for MYH9_CD74 |
![]() |
Fusion gene information | Fusion gene name: MYH9_CD74 | Fusion gene ID: 23002 | Hgene | Tgene | Gene symbol | MYH9 | CD74 | Gene ID | 4627 | 972 |
Gene name | myosin heavy chain 9 | CD74 molecule | |
Synonyms | BDPLT6|DFNA17|EPSTS|FTNS|MHA|NMHC-II-A|NMMHC-IIA|NMMHCA | DHLAG|HLADG|II|Ia-GAMMA | |
Cytomap | 22q12.3 | 5q33.1 | |
Type of gene | protein-coding | protein-coding | |
Description | myosin-9cellular myosin heavy chain, type Amyosin, heavy chain 9, non-musclenon-muscle myosin heavy chain 9non-muscle myosin heavy chain Anon-muscle myosin heavy chain IIanon-muscle myosin heavy polypeptide 9nonmuscle myosin heavy chain II-A | HLA class II histocompatibility antigen gamma chainCD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)CD74 molecule, major histocompatibility complex, class II invariant chainHLA-DR antigens-associated | |
Modification date | 20180522 | 20180522 | |
UniProtAcc | P35579 | P04233 | |
Ensembl transtripts involved in fusion gene | ENST00000216181, ENST00000475726, ENST00000401701, | ENST00000377795, ENST00000353334, ENST00000524315, ENST00000009530, | |
Fusion gene scores | * DoF score | 36 X 33 X 15=17820 | 16 X 15 X 5=1200 |
# samples | 50 | 27 | |
** MAII score | log2(50/17820*10)=-5.1554254317472 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(27/1200*10)=-2.15200309344505 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MYH9 [Title/Abstract] AND CD74 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MYH9 | GO:0001525 | angiogenesis | 16403913 |
Hgene | MYH9 | GO:0006509 | membrane protein ectodomain proteolysis | 16186248 |
Hgene | MYH9 | GO:0030048 | actin filament-based movement | 12237319|15845534 |
Hgene | MYH9 | GO:0031032 | actomyosin structure organization | 24072716 |
Tgene | CD74 | GO:0001516 | prostaglandin biosynthetic process | 12782713 |
Tgene | CD74 | GO:0001934 | positive regulation of protein phosphorylation | 24942581 |
Tgene | CD74 | GO:0002792 | negative regulation of peptide secretion | 19849849 |
Tgene | CD74 | GO:0007165 | signal transduction | 12782713 |
Tgene | CD74 | GO:0008283 | cell proliferation | 12782713 |
Tgene | CD74 | GO:0033674 | positive regulation of kinase activity | 24942581 |
Tgene | CD74 | GO:0043066 | negative regulation of apoptotic process | 12782713 |
Tgene | CD74 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 24942581 |
Tgene | CD74 | GO:0043410 | positive regulation of MAPK cascade | 24942581 |
Tgene | CD74 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 17045821 |
Tgene | CD74 | GO:0045657 | positive regulation of monocyte differentiation | 24942581 |
Tgene | CD74 | GO:0045893 | positive regulation of transcription, DNA-templated | 24942581 |
Tgene | CD74 | GO:0046598 | positive regulation of viral entry into host cell | 24942581 |
Tgene | CD74 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 17045821 |
Tgene | CD74 | GO:0051290 | protein heterotetramerization | 24942581 |
Tgene | CD74 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 17045821|24942581 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | KIRC | TCGA-A3-A6NL-01A | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-5UTR | ENST00000216181 | ENST00000377795 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000216181 | ENST00000353334 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000216181 | ENST00000524315 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000216181 | ENST00000009530 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000475726 | ENST00000377795 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000475726 | ENST00000353334 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000475726 | ENST00000524315 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000475726 | ENST00000009530 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000401701 | ENST00000377795 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000401701 | ENST00000353334 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000401701 | ENST00000524315 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
intron-5UTR | ENST00000401701 | ENST00000009530 | MYH9 | chr22 | 36685235 | - | CD74 | chr5 | 149792314 | - |
Top |
FusionProtFeatures for MYH9_CD74 |
![]() |
Hgene | Tgene |
MYH9 | CD74 |
Cellular myosin that appears to play a role incytokinesis, cell shape, and specialized functions such assecretion and capping. During cell spreading, plays an importantrole in cytoskeleton reorganization, focal contacts formation (inthe margins but not the central part of spreading cells), andlamellipodial retraction; this function is mechanicallyantagonized by MYH10. {ECO:0000269|PubMed:20052411}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MYH9_CD74 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MYH9_CD74 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MYH9 | EPB41, MARK4, ASCC2, MYL9, PRKCE, USP1, USP45, GRB2, RAC1, YWHAZ, EMD, TERF1, TERF2, CBL, PPP2R4, AGO3, YWHAQ, MME, HDAC5, NCOA3, CREBBP, UBE3A, ARRB1, ARRB2, SIRT7, TRAF4, SP1, ISG15, FBXO25, CDK2, CUL1, TRIM72, GRK5, UBASH3B, PIK3R2, SHC1, MYL6, SPTAN1, HSP90AB1, ACTA2, MYH10, HNRNPU, FLNA, ACTR1A, RAB11A, EIF4B, SEL1L, ATP5A1, SEPT7, RALA, HSPA5, TUBA4A, EIF3A, EIF3C, TPM4, MRPS18B, PSME3, HSPA1A, ESR1, TSGA10, EIF4A3, MAGOH, TRAF3IP1, MEN1, HSP90AA1, VCAM1, FN1, IQCB1, ITGA4, PAN2, ACE, ACTB, CSNK2A1, PIK3C3, PPP2CA, CASP4, TARDBP, AKAP10, CDC73, MYH14, OTUD6B, MYL12A, RPA1, RPA2, RPA3, LGR4, IVNS1ABP, TP53, HUWE1, ALK, UBE2I, EED, AMFR, OS9, SYVN1, ATG9A, USP7, HNRNPA1, ATP5L, MYO1E, SRSF5, SSB, NTRK1, ACTA1, ACTG1, ACTN4, ACTN1, AP2A1, AP2B1, ANXA2, APOB, DST, CALD1, CALM1, CALML3, CAPZA1, CAPZA2, CAPZB, CD44, CFL1, CFL2, AP2M1, CLTA, CLTB, CLTC, CPM, DAB2, DAPK3, DBN1, DSG2, CTTN, STOM, EPS15, FLII, FLNB, FYN, GNAI1, GNAI2, GNAS, GNB2, GSN, HIP1, ITPR2, ITPR3, JUP, LGALS1, ABLIM1, LMO7, LSS, LYN, MYO1B, MSN, PDLIM7, ANLN, MYO19, MYO18A, MYLK, MYO1C, MYO5A, MYO5B, MYO6, PPP1R12A, PPP1R12B, NAP1L1, PAWR, PIK3C2A, PLEC, PLS1, PPIA, PPP1CA, PPP1CB, PPP1CC, PSMB10, TWF1, PEX5, RPL22, SIPA1, SORD, SPTBN1, SPTBN2, SSFA2, ST5, SVIL, TCEA2, TMOD1, TNFAIP1, TPM1, TPM2, TPM3, CORO2A, YES1, LUZP1, PICALM, PIP5K1A, SORBS2, IQGAP1, HIP1R, GPRC5A, LRRFIP2, CLINT1, ARHGAP11A, ARHGEF17, SEC16A, WDR1, ARPC4, ARPC3, ARPC1B, ACTR3, ACTR2, ARPC2, BCAP31, FLOT1, BASP1, IMMT, RBPMS, DSTN, TRIOBP, CEP250, AKAP2, TWF2, SYNPO, CEP162, LIMCH1, PALLD, SIPA1L3, MPRIP, COBL, KIF13B, SPECC1L, ATP13A2, MACF1, CORO1C, STX12, GCA, PLEKHG3, RAI14, ZBTB20, AHDC1, PACSIN3, TMOD3, PNMA3, FCF1, CEP83, LIMA1, GTSE1, KDM3B, UACA, CDCA8, BMP2K, UNC45A, MYO5C, GNG12, MUC13, CORO1B, MICAL3, ARHGAP21, SHROOM3, AFAP1, INF2, NARFL, METTL17, AHNAK, EFHD2, CYBRD1, WDR76, DSN1, RNF170, TRIM56, ARPC5L, ANTXR1, LZTS2, PPP1R9B, CEP89, STON2, DOCK7, DIXDC1, SSH2, NEXN, ELMSAN1, SPECC1, CCDC102A, FCHO2, MISP, JMY, CD109, ACTRT1, MYL6B, CCDC50, OARD1, GAS2L3, TTLL6, TPRN, ACTBL2, MCM2, MCM5, SNW1, CDC5L, BOP1, PES1, EGFR, CDH1, C9orf156, MYL3, H2AFY, CYLD, TRIM25, BRCA1, HDAC6 | CD74 | MIF, CD74, APP, HADHA, LAMTOR5, MAP3K1, TM4SF20, COPG1, COPG2, HLA-DPB1, HLA-DQA1, CD44 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MYH9_CD74 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | MYH9 | P35579 | DB11638 | Artenimol | Myosin-9 | small molecule | approved|investigational |
Top |
RelatedDiseases for MYH9_CD74 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MYH9 | C0403445 | Fechtner syndrome (disorder) | 9 | UNIPROT |
Hgene | MYH9 | C0398641 | Epstein syndrome (disorder) | 7 | UNIPROT |
Hgene | MYH9 | C0340978 | May-Hegglin anomaly | 6 | UNIPROT |
Hgene | MYH9 | C0022661 | Kidney Failure, Chronic | 2 | CTD_human |
Hgene | MYH9 | C1854520 | SEBASTIAN SYNDROME | 2 | CTD_human;ORPHANET;UNIPROT |
Hgene | MYH9 | C0017668 | Focal glomerulosclerosis | 1 | CTD_human |
Hgene | MYH9 | C0020544 | Renal hypertension | 1 | CTD_human |
Hgene | MYH9 | C0027706 | Hereditary nephritis | 1 | CTD_human |
Hgene | MYH9 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | MYH9 | C1863659 | DEAFNESS, AUTOSOMAL DOMINANT 17 | 1 | UNIPROT |
Hgene | MYH9 | C2673482 | Increased susceptibility to schizophrenia | 1 | PSYGENET |
Tgene | CD74 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | CD74 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CD74 | C0162557 | Liver Failure, Acute | 1 | CTD_human |
Tgene | CD74 | C1458155 | Mammary Neoplasms | 1 | CTD_human |